Antonio Marchetti
Antonio Marchetti
Verified email at
Cited by
Cited by
EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening†…
A Marchetti, C Martella, L Felicioni, F Barassi, S Salvatore, A Chella, ...
Journal of clinical oncology 23 (4), 857-865, 2005
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
A Marchetti, L Felicioni, S Malatesta, M Grazia Sciarrotta, L Guetti, ...
Journal of clinical oncology 29 (26), 3574-3579, 2011
Increased MET gene copy number negatively affects survival of surgically resected non–small-cell lung cancer patients
F Cappuzzo, A Marchetti, M Skokan, E Rossi, S Gajapathy, L Felicioni, ...
Journal of clinical oncology 27 (10), 1667, 2009
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
The Hippo effector YAP promotes resistance to RAF-and MEK-targeted cancer therapies
L Lin, AJ Sabnis, E Chan, V Olivas, L Cade, E Pazarentzos, S Asthana, ...
Nature genetics 47 (3), 250-256, 2015
IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors
FE Bleeker, S Lamba, S Leenstra, D Troost, T Hulsebos, WP Vandertop, ...
Human mutation 30 (1), 7-11, 2009
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer
R Cazzoli, F Buttitta, M Di Nicola, S Malatesta, A Marchetti, WN Rom, ...
Journal of thoracic oncology 8 (9), 1156-1162, 2013
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
Survivin gene expression in early‐stage non‐small cell lung cancer
M Falleni, C Pellegrini, A Marchetti, B Oprandi, F Buttitta, F Barassi, ...
The Journal of Pathology: A Journal of the Pathological Society of Great†…, 2003
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ...
Annals of Oncology 25 (9), 1681-1690, 2014
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop
R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ...
Journal of Thoracic Oncology 5 (10), 1706-1713, 2010
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, P Meldgaard, M Nicolson, L Paz-Ares, M Reck, ...
Annals of Oncology 25 (8), 1475-1484, 2014
Association between Cigarette Smoking and FHIT Gene Alterations in Lung Cancer
G Sozzi, L Sard, L De Gregorio, A Marchetti, K Musso, F Buttitta, ...
Cancer research 57 (11), 2121-2123, 1997
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ...
Clinical Cancer Research 13 (20), 6064-6069, 2007
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
L Bubendorf, R BŁttner, F Al-Dayel, M Dietel, G Elmberger, K Kerr, ...
Virchows Archiv 469, 489-503, 2016
AKT1E17K in human solid tumours
FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ...
Oncogene 27 (42), 5648-5650, 2008
Assessing EGFR mutations.
A Marchetti, L Felicioni, F Buttitta
New England Journal of Medicine 354, 526-528, 2006
A unique microRNA signature associated with plaque instability in humans
F Cipollone, L Felicioni, R Sarzani, S Ucchino, F Spigonardo, C Mandolini, ...
Stroke 42 (9), 2556-2563, 2011
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features
F Buttitta, F Barassi, G Fresu, L Felicioni, A Chella, D Paolizzi, G Lattanzio, ...
International journal of cancer 119 (11), 2586-2591, 2006
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study
F Buttitta, A Marchetti, A Gadducci, S Pellegrini, M Morganti, V Carnicelli, ...
British journal of cancer 75 (2), 230-235, 1997
The system can't perform the operation now. Try again later.
Articles 1–20